Protecting Innovation and America’s Future
The Midsized Biotech Alliance of America (MBAA) unites the bold innovators driving
U.S. biotech breakthroughs. Our members are investing in research, jobs, and cures that
keep America first in life-changing medicine.
$
0
B Annually in R&D
0
High-Skill Workers
0
Transformative Therapies
0
+ Therapies in Development
Our success, and the future of U.S. innovation, depends on sound policy that rewards risk-taking, investment, and discovery. The MBAA advocates for policies that sustain innovation, expand access, and keep the United States the global leader in biotechnology.
MBAA’s mission is guided by three principles:
Facilitating Patient
Access
Ensuring all Americans can benefit from innovative medicines.
Strengthening the
U.S. Economy
Encouraging policies that support U.S.-based R&D and manufacturing
Protecting the Pipeline of American Innovation
Protecting the companies closest to the patient, and the next wave of cures